Donald L. Hagan LLC’s AbbVie ABBV Stock Holding History

Donald L. Hagan LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,397	Closed	-$731K	–	94
2021 Q4	$731K	Buy	5,397 +85	+2%	+$10K	0.38%	62
2021 Q3	$573K	Sell	5,312 -1,943	-27%	-$222K	0.33%	67
2021 Q2	$817K	Sell	7,255 -27	-0.4%	-$3.04K	0.48%	48
2021 Q1	$788K	Sell	7,282 -3,048	-30%	-$326K	0.52%	36
2020 Q4	$1.11M	Sell	10,330 -1,164	-10%	-$112K	0.81%	22
2020 Q3	$1.01M	Sell	11,494 -5,444	-32%	-$513K	0.8%	23
2020 Q2	$1.66M	Sell	16,938 -2,481	-13%	-$218K	1.45%	10
2020 Q1	$1.59M	Buy	+19,419	New	+$1.65M	1.43%	13
2016 Q2	–	Sell	-1,209	Closed	-$69K	–	86
2016 Q1	$69K	Buy	+1,209	New	+$67.4K	0.06%	122
2015 Q4	–	Sell	-1,309	Closed	-$71K	–	75
2015 Q3	$71K	Buy	+1,309	New	+$85.2K	0.06%	112

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Donald L. Hagan LLC's ABBV Position: Q1 2022 in Review

Donald L. Hagan LLC sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 5,397 shares — an estimated $731K sold.

Donald L. Hagan LLC first reported a position in ABBV in Q3 2015 and held it in 10 quarters. The position peaked at $1.66M in Q2 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Donald L. Hagan LLC reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
Donald L. Hagan LLC sold 5,397 AbbVie shares in Q1 2022, an estimated $731K.
Donald L. Hagan LLC first reported a position in AbbVie in Q3 2015 and held it in 10 quarters.
Donald L. Hagan LLC's AbbVie position peaked at $1.66M in Q2 2020.
3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Donald L. Hagan LLC's 13F filing for Q1 2022, filed 18 Apr 2022.